9-乙酰氧基乙基-6-烷氨基-2-烷硫基嘌呤的合成及抗血小板凝集活性评估

以2-氨基-6-氯嘌呤(1)为原料,与2-溴乙基乙酸酯反应得到9-乙酰氧基乙基-2-氨基-6-氯嘌呤(2);2经重氮-烷硫化得到9-乙酰氧基乙基-2-烷硫基-6-氯嘌呤(3);3经胺解反应得到14个未见报道的9-乙酰氧基乙基-6-烷氨基-2-烷硫基嘌呤化合物4.这些化合物的结构经IR,1H NMR,13C NMR及HRMS得到表征,同时进行了抗血小板凝集活性测试.     

合成2-氟腺嘌呤的新方法

从2-氨基-6-氯嘌呤出发,通过叠氮化反应合成2-氨基-6-叠氮嘌呤(3),3在希曼反应中完成氟对氨基的取代得到2-氟-6-叠氮嘌呤(4),4的叠氮基被还原为氨基制备出目标化合物2-氟腺嘌呤,总收率39.3%。     

6-氯-8-烃基-9-芳基嘌呤类衍生物的合成

以4,6-二氯-5-氨基嘧啶为原料,经N-烃基化反应、缩合反应和氯化反应,合成了一系列未见文献报道的6-氯-8-烃基-9-芳基嘌呤衍生物,所有化合物均通过1H NMR、MS和元素分析确定其结构。 研究结果表明,N-烃基化反应时,芳胺使用盐酸作催化剂,芳基脂肪胺用有机碱三乙胺作催化剂,缩合反应时,多聚磷酸(PPA)用量过多会影响传质效果,影响反应的收率。 讨论了微波反应方式对氯化反应的影响。     

2-氨基-4-甲氧基氯代苯甲酸的合成研究

以2-氨基-4-甲氧基苯甲酸甲酯为原料,通过氯代反应,再分别通过酯水解反应得到化合物2-氨基-5-氯-4-甲氧基苯甲酸和2-氨基-3-氯-4-甲氧基苯甲酸。其中间体及产物结构经~1H NMR、~(13)C NMR和ESI-MS确证,并考察了最佳氯代反应条件。结果表明:物料配比为n(2-氨基-4-甲氧基苯甲酸甲酯)∶n(NCS)=1∶1. 2,反应溶剂为N,N-二甲基甲酰胺,反应时间为16 h,两种氯代产物2-氨基-5-氯-4-甲氧基苯甲酸甲酯和2-氨基-3-氯-4-甲氧基苯甲酸甲酯收率分别为47%和39%。     

2-氨基-6-氟-9-(4-羟基-3-羟甲基丁基)嘌呤的合成

报道了2-氨基-6-氟-9-(4-羟基-3-羟甲基丁基)嘌呤(1)的合成, 通过对起始原料2-氨基-6-氯-9-(4-乙酰氧基-3-乙酰氧甲基丁基)嘌呤(2)水解脱去乙酰基, 得到2-氨基-6-氯-9-(4-羟基-3-羟甲基丁基)嘌呤(3). 化合物3与三甲胺乙醇溶液在混合溶剂[V(THF)∶V(DMF)＝3∶1]中反应得到相应的氯化铵盐4, 然后与KF在DMF溶剂中反应, 得到化合物1. 产品经UV-vis, IR, ¹H NMR, ¹⁹F NMR和MS表征. 考察了反应温度、氟化试剂等因素对氟化反应的影响, 为6位含氟的嘌呤核苷类化合物的合成提供了一种直接、简易的新方法.     

相转移催化合成4-{2-[N-甲基-N-(2-吡啶基)]氨基乙氧基}苯甲醛

以2-氯吡啶(1)、2-甲氨基乙醇(2)和4-氟苯甲醛(4)为主要原料,经2步反应合成了4-{2-[N-甲基-N-(2-吡啶基)氨基乙氧基]}苯甲醛(5).第1步反应n(2)∶n(1)=4∶1,反应温度160℃,反应时间约6h,采用减压蒸馏进行后处理,2-[N-甲基-N-(2-吡啶基)氨基]乙醇(3)的收率在93％以上,过量2的回收率在97％以上,回收的2可以重复使用.第2步反应用氢氧化钠做碱性试剂,用甲苯和水分别做为两相的溶剂,在相转移催化剂CTAB作用下进行,经优化后5的收率可达90％以上.2步反应总收率达83％以上.     

新型2,6,9-三取代嘌呤衍生物的合成及抗血小板凝集活性

以9-乙酰氧基乙基-2-丙硫基-6-氯嘌呤化合物(1)为原料,经烷胺化和玻沃-布兰还原制得2-(6-烷氨基-2-丙硫基-9H-嘌呤-9-基)乙醇(2a~2d); 2a~2d与二苄基磷酰氯反应制得2-(6-烷氨基-2-丙硫基-9H-嘌呤-9-基)乙基二苄基磷酸酯(3a~3d); 3a~3d与三甲基溴硅烷反应合成了2-(6-烷氨基-2-丙硫基-9H-嘌呤-9-基)乙基磷酸二氢酯化合物(4a~4d)，化合物3与化合物4均为新化合物，其结构经¹H NMR, ¹³C NMR, ³¹P NMR, IR和HR-MS（ESI）表征。研究了3a~3d, 4a~4d的抗血小板凝集活性。结果表明：含有磷酸基团的嘌呤化合物活性明显优于不含磷酸基团嘌呤化合物的活性,其中4b活性最好，抗血小板凝集活性为17.79%。     

N-(3-十六烷氧基-2-羟基丙基)-N,N-二甲基甜菜碱的制备

以十六醇、环氧氯丙烷、二甲胺和氯乙酸钠等为原料,通过三步反应合成N-(3-十六烷氧基-2-羟基丙基)-N,N-二甲基甜菜碱(HHDB),并探索了反应温度、投料比、反应时间和催化剂等因素对产物产率的影响,确定了最佳反应条件。中间体3-十六烷氧基-2-羟基-1-氯丙烷(HHCP)合成的最佳工艺条件:催化剂苄基三乙基氯化铵,体系p H为9.0,n(C_(16)H_(33)OH)∶n(C_3H_5OCl)=1∶1.1,滴加环氧氯丙烷温度65℃,滴加时间1.5h,反应温度95℃,反应时间5 h;中间体N-(3-十六烷氧基-2-羟基丙基)-N,N-二甲基叔胺(HHDT)合成的最佳工艺条件:n(C_(19)H_(39)OCl)∶n(C_2H_7N)=1∶1.2,反应温度85℃,反应时间20 h;产物HHDB制备的最佳工艺条件:n(C_(21)H_(45)ON)∶n(C_3H_4O_2ClNa)=1∶1.1,反应温度80℃,反应时间4 h。在上述工艺条件下,HHDB产率达到95.2%,对产物HHDB及中间体进行红外光谱与核磁氢谱表征,测定其临界胶束浓度为9.8 mmol·L-1,水溶液表面张力为18.8 m N·m-1,发泡力为1.15,产物具有较好的表面活性。     

N6-烷基-2-烷氧基腺苷化合物的合成及抗血小板凝集活性

以鸟瞟呤核苷(1)为原料,经羟基保护得到2’,3’,5’-三-O-乙酰基鸟嘌呤核苷(2),2与三氯氧磷反应得到2-氨基-6-氯-9-(2’,3’,5’-三-O-乙酰基-β-D-呋喃核糖)嘌呤(3),3经重氮化、水解和O-烷基化得到2-烷氧基-6-氯-9-(2’,3’,5’-三-O-乙酰基-β-D-呋喃核糖)嘌呤(4a～...     

N-(2-吡啶甲基)取代的阿伐那非类似物的合成条件优化

以4-(3-氯-4-甲氧基苄基氨基)-2-[(2S)-2-羟甲基-1-吡咯烷基]-5-嘧啶羧酸乙酯为原料,合成了4-(3-氯-4-甲氧基苄基氨基)-2-[(2S)-2-羟甲基-1-吡咯烷基]-N-(2-吡啶甲基)-5-嘧啶甲酰胺,研究了此种阿伐那非类似物的合成条件优化,考察了投料比、反应温度、反应时间等因素对产率的影响.获得较高产率的反应条件为n(C6H8N2)∶n(C18H21ClN4O4)∶n(EDCI)∶n(HOBt)∶n(Et3N)=1.2∶1∶1.2∶1.2∶2,在搅拌下,60℃反应6h,经过后处理,柱层析纯化,得到类白色固体产物,产率为84.3%.所合成的产物经FT-IR、1 H NMR、13 C NMR、ESI-MS得到验证.     

Design, synthesis, conformational analysis and biological activities of purine-based 1,2-di-substituted carbocyclic nucleosides

New 1,2-di-substituted carbocyclic nucleosides with 6-chloropurine, adenine and hypoxanthine bases were synthesized by construction of purine on the primary amino group of (+/-)-trans-2-aminocyclopentylmethanol. AM1 calculations showed close correspondence between the positions of the heteroatoms in the adenine derivative and dideoxyadenosine. The most active of the new compounds in antiviral assays and antitumoral assays against L1210/0, MOLT4/C8 and CEM/0 cells was the 6-chloropurine derivative.     

Nucleic acid related compounds. 118. Nonaqueous diazotization of aminopurine derivatives. Convenient access to 6-halo- and 2,6-dihalopurine nucleosides and 2'-deoxynucleosides with acyl or silyl halides

Treatment of 9-(2,3,5-tri-O-acetyl-beta-d-ribofuranosyl)-2-amino-6-chloropurine (1) with TMS-Cl and benzyltriethylammonium nitrite (BTEA-NO2) in dichloromethane gave the crystalline 2,6-dichloropurine nucleoside 2, and acetyl chloride/BTEA-NO2 was equally effective ( approximately 85%, without chromatography). TMS-Br/tert-butyl nitrite/dibromomethane gave crystalline 2-bromo-6-chloro analogue 3 (85%). (Chloro or bromo)-dediazoniation of 3',5'-di-O-acetyl-2'-deoxyadenosine (4) gave the 6-[chloro (5, 63%) or bromo (6, 80%)]purine deoxynucleosides, and 2',3',5'-tri-O-acetyladenosine (8) was converted into the 6-chloropurine nucleoside 9 (71%).     

Nucleosides. CXXXV. Synthesis of some 9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purines and their biological activities

Seven purine nucleosides containing the 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl moiety were synthesized and tested for their antitumor activity. Direct condensation of 3-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-D-arabinofuranosyl bromide (1) with N6-benzoyladenine in CH2Cl2 followed by saponification of the product afforded the adenine nucleoside (I, 2'-F-ara-A). Deamination of I with NaNO2 in HOAc gave the hypoxanthine analogue (II, 2'-F-ara-H). The 6-thiopurine nucleoside (III, 2'-F-ara-6MP) was prepared by condensation of 1 with 6-chloropurine by the mercury procedure followed by thiourea treatment and saponification of the product. Methylation of III gave the 6-SCH3 analogue (IV). Raney Ni desulfurization of III afforded the unsubstituted purine nucleoside (V, 2'-F-ara-P). Condensation of 1 with 2-acetamido-6-chloropurine by the silyl procedure afforded the protected 2-acetamido-6-chloropurine nucleoside which served as the precursor for both the guanine and 6-thioguanine nucleosides (VI, 2'-F-ara-G and VII, 2'-F-ara-TG, respectively). Thus, alkaline hydrolysis of the precursor gave VI. Thiourea treatment prior to alkaline hydrolysis gave VII. The new nucleoside, 2'-F-ara-G (VI) is found to be selectively toxic to human T-cell leukemia CCRF-CEM.     

水介质中高分子配体负载微粒钯催化Suzuki偶联反应

对Wang树脂进行改性,制备了高分子负载纳米钯催化剂,并将其应用于水介质中卤代芳烃与芳硼酸的Suzuki偶联反应。 以溴苯和苯硼酸的偶联反应为模型,考察了溶剂、温度、碱种类、催化剂用量对反应的影响,确定较佳的反应条件为：n(C₆H₅Br)∶n(C₆H₅B(OH)₂)∶n(WRP-Pd)∶n(K₂CO₃)∶n(TBAB)=1.0∶1.5∶0.005∶2.0∶0.5,反应温度100℃, 反应时间4 h。 用氯代芳烃代替溴代芳烃反应时,延长反应时间,也能得到较高产率。 催化剂经过简单的过滤洗涤后,重复使用4次活性无明显降低。     

合成E-10-羟基-2-癸烯酸的新方法

以1,8-辛二醇（1）为起始原料,经4步反应合成了（E）-10-羟基-2-癸烯酸,其结构经¹H NMR, ¹³C NMR和MS确证。考察了乙酰氯、缚酸剂种类及其用量［r=n（1）: n（乙酰氯）: n（缚酸剂）］对8-乙酰氧基-1-辛醇（2）收率的影响以及反应温度、三乙胺滴加温度、低温停留时间对8-乙酰氧基辛醛（3）收率的影响。结果表明：以三乙胺为缚酸剂,r=1.0 : 1.1 : 2.0时,2产率达78%;反应温度为-65 ℃、三乙胺滴加温度低于-50 ℃、低温反应3 h, 3产率达97%。     

Microwave promoted C6-alkylation of purines through S(N)Ar-based reaction of 6-chloropurines with 3-alkyl-acetylacetone

C6-Alkylated purine analogues were obtained in good to excellent isolated yields by S(N)Ar reaction of 6-chloropurine derivatives with 3-alkyl-acetylacetone. 3-Alkyl-acetylacetones were employed as alkylating agents and C6-alkylated purines were obtained highly selectively within short reaction time under microwave irradiation conditions. This work is complementary to the classical coupling reactions for the synthesis of C6-alkylated purine analogues.     

Nucleic acid related compounds. 116. Nonaqueous diazotization of aminopurine nucleosides. Mechanistic considerations and efficient procedures with tert-butyl nitrite or sodium nitrite

Nonaqueous diazotization-dediazoniation of two types of aminopurine nucleoside derivatives has been investigated. Treatment of 9-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)-2-amino-6-chloropurine (1) with SbCl(3)/CH(2)Cl(2) was examined with benzyltriethylammonium (BTEA) chloride as a soluble halide source and tert-butyl nitrite (TBN) or sodium nitrite as the diazotization reagent. Optimized yields (>80%) of the 2,6-dichloropurine derivative were obtained with SbCl(3). Combinations with SbBr(3)/CH(2)Br(2) gave the 2-bromo-6-chloropurine product (>60%), and SbI(3)/CH(2)I(2)/THF gave the 2-iodo-6-chloropurine derivative (>45%). Antimony trihalide catalysis was highly beneficial. Mixed combinations (SbX(3)/CH(2)X'(2); X/X' = Br/Cl) gave mixtures of 2-(bromo, chloro, and hydro)-6-chloropurine derivatives that were dependent on reaction conditions. Addition of iodoacetic acid (IAA) resulted in diversion of purine radical species into a 2-iodo-6-chloropurine derivative with commensurate loss of other radical-derived products. This allowed evaluation of the efficiency of SbX(3)-promoted cation-derived dediazoniations relative to radical-derived reactions. Efficient conversions of adenosine, 2'-deoxyadenosine, and related adenine nucleosides into 6-halopurine derivatives of current interest were developed with analogous combinations.     

4-羟丁基缩水甘油醚的合成

以1,4-丁二醇（BDO）和环氧氯丙烷(ECH）为原料,经一步法合成了丙烯酸羟丁基缩水甘油醚中间体4-羟丁基缩水甘油醚（4-HBGE）,其结构经¹H NMR和MS(ESI)确证。对反应条件进行了优化,最佳反应条件为：BDO 0.1 mol,四丁基溴化铵(5 wt%)为催化剂,n(ECH: n(BDO)为1 : 2, n(NaOH) : n(BDO)=1:1.5,甲苯/水（V/V=1/1）为溶剂,于40 ℃反应6 h,经二级萃取法提纯,4-HBGE收率和纯度分别为69.5%和97.6%。     

Preparative electrochemical reduction of 2-amino-6-chloropurine and synthesis of 6-deoxyacyclovir, a fluorescent substrate of xanthine oxidase and a prodrug of acyclovir

D.c. polarography of 2-amino-6-chloropurine in aqueous medium over a broad pH range revealed two diffusion waves, the first of which corresponds to reduction of the C(6)-Cl bond, leading to formation of 2-aminopurine in high yield. Condensation of the sodium salt of 2-aminopurine with (2-acetoxyethoxy)methyl chloride led to the two isomeric 9- and 7-(2-hydroxyethoxymethyl)-2-aminopurines. The 9- isomer, 6-deoxyacyclovir, a prodrug of acyclovir previously synthesized by another route, was readily converted to the latter by xanthine oxidase; the 7-isomer was not a substrate. The intense fluorescence of 6-deoxyacyclovir makes it a convenient fluorescent substrate for xanthine oxidase, although less sensitive than xanthine; it is shown that 2-aminopurine would be a very sensitive fluorescent substrate. The polarographic behaviour of the riboside of 2-amino-6-chloropurine was virtually identical with that of the parent purine, leading to a simple procedure for conversion of 2-amino-6-chloropurine nucleosides and acyclonucleosides to the corresponding 2-aminopurine congeners.     

相转移催化法合成肉桂酸

用K2CO3作催化剂、PEG 400作相转移催化剂,对肉桂酸的合成工艺进行了研究.最佳条件为n(苯甲醛)∶n(乙酸酐)∶n(碳酸钾)=1∶3.25∶1,10mLPEG 400/0.1mol苯甲醛,反应时间1h,反应温度140～150℃,收率可达77.4%.